AGNG


Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2021

Key Information As of 09/29/22

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $37.25 million
NAV $23.58
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 09/29/22

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 1,580,000
Number of Holdings 99
30-Day Median Bid-Ask Spread 0.37%

Distributions As of 09/29/22

30-Day SEC Yield 0.85%
Distribution Frequency Semi-Annually

ETF Prices As of 09/29/22

NAV $23.58 Daily Change -$0.21 -0.88%
Market Price $23.48 Daily Change -$0.41 -1.72%

Performance History

As of recent
(06/30/22)
As of recent
(06/30/22)
Fund NAV Market Price Index
1 Year -16.41% -16.31% -16.35%
3 Years 6.56% 6.66% 6.76%
5 Years 7.15% 6.97% 7.37%
Since Inception 9.42% 9.84% 9.70%
1 Year -19.60% -20.07% -19.52%
3 Years 5.62% 5.32% 5.81%
5 Years 5.99% 5.81% 6.20%
Since Inception 8.72% 9.02% 8.99%
Year-to-Date -12.15% -11.85% -12.11%
1 Month -3.04% -3.07% -3.03%
3 Months -11.63% -11.39% -11.61%
Since Inception 73.89% 78.04% 76.60%
Year-to-Date -14.35% -14.57% -14.28%
1 Month -6.00% -6.66% -6.02%
3 Months -5.46% -6.06% -5.43%
Since Inception 69.54% 72.55% 72.23%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 09/29/22

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
4.01 LLY ELI LILLY & CO 2516152 330.01 4,530 1,494,945.30
3.67 REGN REGENERON PHARMACEUTICALS 2730190 691.82 1,977 1,367,728.14
3.55 BMY BRISTOL-MYERS SQUIBB CO 2126335 71.71 18,457 1,323,551.47
3.41 AMGN AMGEN INC 2023607 228.41 5,563 1,270,644.83
3.37 JNJ JOHNSON & JOHNSON 2475833 164.53 7,632 1,255,692.96
3.29 BSX BOSTON SCIENTIFIC CORP 2113434 39.34 31,161 1,225,873.74
3.24 NOVOB DC NOVO NORDISK A/S-B BHC8X90 100.43 12,002 1,205,393.90
3.17 RO SW ROCHE HOLDING AG-BR 7108918 394.09 2,997 1,181,080.73
3.15 ABBV ABBVIE INC B92SR70 142.72 8,228 1,174,300.16
3.06 BIIB BIOGEN INC 2455965 264.28 4,318 1,141,161.04
2.97 AZN ASTRAZENECA PLC-SPONS ADR 2989044 54.91 20,117 1,104,624.47
2.84 SYK STRYKER CORP 2853688 205.48 5,155 1,059,249.40
2.83 4519 JP CHUGAI PHARMA CO 6196408 25.10 41,923 1,052,460.25
2.74 MDT MEDTRONIC PLC BTN1Y11 82.27 12,421 1,021,875.67
2.67 ALC SW ALCON INC BJT1GR5 56.51 17,584 993,737.98
2.58 EW EDWARDS LIFESCIENCES CORP 2567116 83.83 11,458 960,524.14
2.44 WELL WELLTOWER INC BYVYHH4 63.33 14,337 907,962.21
2.39 DXCM DEXCOM INC B0796X4 82.10 10,825 888,732.50
1.97 SGEN SEAGEN INC BLPK4D2 135.70 5,404 733,322.80
1.92 4503 JP ASTELLAS PHARMA INC 6985383 13.17 54,162 713,569.69
1.78 ZBH ZIMMER BIOMET HO 2783815 107.12 6,183 662,322.96
1.71 4543 JP TERUMO CORP 6885074 28.41 22,414 636,790.43
1.67 GMAB DC GENMAB A/S 4595739 318.88 1,951 622,143.01
1.30 068270 KS CELLTRION INC B0C5YV1 118.84 4,062 482,731.25
1.27 PODD INSULET CORP B1XGNW4 231.18 2,040 471,607.20
1.24 VTR VENTAS INC 2927925 39.20 11,780 461,776.00
1.16 INCY INCYTE CORP 2471950 66.61 6,505 433,298.05
1.11 BGNE BEIGENE LTD-ADR BYYWPW6 136.28 3,034 413,473.52
1.10 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 87.69 4,690 411,247.50
1.08 SOON SW SONOVA HOLDING AG-REG 7156036 215.90 1,857 400,930.28
1.07 UCB BB UCB SA 5596991 69.46 5,754 399,668.41
0.88 ABMD ABIOMED INC 2003698 248.96 1,323 329,374.08
0.78 SN/ LN SMITH & NEPHEW PLC 0922320 11.29 25,752 290,837.76
0.77 NBIX NEUROCRINE BIOSC 2623911 102.76 2,798 287,522.48
0.75 TFX TELEFLEX INC 2881407 203.97 1,374 280,254.78
0.75 UTHR UNITED THERAPEUTICS CORP 2430412 207.94 1,346 279,887.24
0.75 3692 HK HANSOH PHARMACEU BJYKB72 1.60 174,743 279,147.15
0.75 AGL AGILON HEALTH INC BLR4TK4 23.52 11,817 277,935.84
0.71 COH AU COCHLEAR LTD 6211798 134.92 1,950 263,101.25
0.65 AERI AERIE PHARMACEUTICALS INC BFRTDG1 15.12 15,907 240,513.84
0.64 FME GR FRESENIUS MEDICA 5129074 27.75 8,637 239,647.21
0.64 DVA DAVITA INC 2898087 83.96 2,838 238,278.48
0.63 NVCR NOVOCURE LTD BYSS4X4 77.05 3,057 235,541.85
0.57 CANO CANO HEALTH INC BN0WWW2 8.67 24,527 212,649.09
0.57 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 1.00 211,189 211,460.72
0.54 OHI OMEGA HEALTHCARE 2043274 28.78 7,022 202,093.16
0.46 AMP IM AMPLIFON SPA B14NJ71 25.45 6,683 170,092.08
0.46 EXAS EXACT SCIENCES CORP 2719951 33.17 5,115 169,664.55
0.45 DEMANT DC DEMANT A/S BZ01RF1 23.86 7,071 168,694.34
0.45 1858 HK BEIJING CHUNLI-H BVVPXP6 1.47 113,616 166,735.41
0.43 HALO HALOZYME THERAPEUTICS INC 2975098 39.52 4,041 159,700.32
0.41 LHCG LHC GROUP INC B06DT50 164.29 928 152,461.12
0.40 SILK SILK ROAD MEDICAL INC BGHVXJ7 46.73 3,209 149,956.57
0.40 EXEL EXELIXIS INC 2576941 15.84 9,391 148,753.44
0.38 FGEN FIBROGEN INC BSDRYR8 13.26 10,772 142,836.72
0.38 TBPH THERAVANCE BIOPHARMA INC BMNDK09 10.11 14,126 142,813.86
0.37 CMAX CAREMAX INC BMD9BG0 7.60 18,033 137,050.80
0.36 LTC LTC PROPERTIES INC 2498788 36.50 3,669 133,918.50
0.36 NHI NATL HEALTH INVESTORS INC 2626125 55.31 2,418 133,739.58
0.35 ENSG ENSIGN GROUP INC/THE B1YWPP8 80.95 1,629 131,867.55
0.35 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.33 399,692 131,365.41
0.35 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 28.57 4,587 131,050.59
0.35 ANGO ANGIODYNAMICS INC B00CR04 20.57 6,361 130,845.77
0.35 NHC NATIONAL HEALTHCARE CORP 2139731 66.02 1,967 129,861.34
0.34 BPMC BLUEPRINT MEDICINES CORP BWY52P3 65.86 1,946 128,163.56
0.34 SBRA SABRA HEALTH CAR B5NLBP6 12.76 9,860 125,813.60
0.33 4547 JP KISSEI PHARM CO 6494061 17.64 6,998 123,461.38
0.33 8086 JP NIPRO CORP 6641599 7.52 16,413 123,385.53
0.33 CASH 1.00 121,771 121,781.85
0.32 MMSI MERIT MEDICAL SYSTEMS INC 2580555 57.07 2,115 120,703.05
0.32 DNLI DENALI THERAPEUTICS INC BD2B4V0 29.29 4,113 120,469.77
0.32 GKOS GLAUKOS CORP BYMWL19 53.53 2,250 120,442.50
0.31 NUVA NUVASIVE INC B00GJC2 44.82 2,560 114,739.20
0.30 ITGR INTEGER HOLDINGS CORP BD06LM7 62.87 1,783 112,097.21
0.29 RYM NZ RYMAN HEALTHCARE LTD 6161525 4.89 21,841 106,773.42
0.28 MNKD MANNKIND CORP BF081J4 2.99 34,982 104,596.18
0.28 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.28 375,824 104,370.29
0.27 853 HK MICROPORT SCIENTIFIC CORP B676TW7 1.75 58,302 102,048.37
0.27 INGN INOGEN INC BJSVLL5 24.08 4,156 100,076.48
0.27 AMED AMEDISYS INC 2024332 100.45 986 99,043.70
0.25 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 8.49 11,019 93,602.65
0.25 ATEC ALPHATEC HOLDINGS INC BD60BG7 8.71 10,683 93,048.93
0.25 ALEC ALECTOR INC BJ4LDC4 9.45 9,755 92,184.75
0.24 BKD BROOKDALE SR B0PZN33 4.29 20,413 87,571.77
0.24 HRTX HERON THERAPEUTICS INC BJ0XLZ3 4.01 21,823 87,510.23
0.23 CSH-U CN CHARTWELL RETIRE B8S8C94 6.63 13,142 87,105.46
0.23 PHM SM PHARMA MAR SA BMW2GT8 52.56 1,653 86,886.99
0.23 2500 HK VENUS MEDTECH -H BL6V047 1.20 71,440 85,547.08
0.23 EKTAB SS ELEKTA AB-B SHS B0M42T2 4.84 17,616 85,312.30
0.22 LIVN LIVANOVA PLC BYMT0J1 48.37 1,721 83,244.77
0.22 ACAD ACADIA PHARMACEU 2713317 16.14 5,045 81,426.30
0.22 PNTG PENNANT GROUP INC/THE BKTC976 10.76 7,520 80,915.20
0.21 AED BB AEDIFICA B1G5XP1 73.25 1,079 79,035.27
0.20 GN DC GN STORE NORD A/S 4501093 17.65 4,240 74,842.69
0.19 SGHT SIGHT SCIENCES INC BN2T5Q6 6.10 11,513 70,229.30
0.17 KORI FP KORIAN B1HKRM0 9.73 6,349 61,759.37
0.13 DHC DIVERSIFIED HEAL BKRN595 0.99 47,487 47,183.08
0.11 AMRN AMARIN CORP PLC -ADR 2301938 1.10 37,142 40,856.20
0.10 ORP FP ORPEA 7339451 10.25 3,506 35,953.36
0.00 RADIUS HEALTH INC - CVR 0.00 19,104 0.00
Holdings are subject to change.

Sector Breakdown As of 08/31/22

Sector Weight (%)
Health Care 93.5
Real Estate 6.5

Source: AltaVista Research, LLC

Country Breakdown As of 08/31/22

Country Weight (%)
United States 59.2
Switzerland 8.7
Japan 7.3
Denmark 5.9
Britain 4.9
China 4.3
Ireland 2.9
South Korea 1.4
Belgium 1.3
Germany 0.8
Australia 0.7
Other/Cash 2.6

Source: AltaVista Research, LLC

ETF Characteristics As of 09/29/22

Return on Equity 12.70%
Weighted Avg. Market Cap 86,836 M
2021 2022
Price-to-earnings 23.16 25.03
Price-to-book value 3.30 3.06

Source: AltaVista Research, LLC

ETF Risk Stats As of 08/31/22

Versus Beta
S&P 500 0.76
MSCI EAFE 0.77
MSCI Emg. Mkts 0.62
Standard Deviation 18.20%

Source: AltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

Back to Top